Researchers at The Ottawa Hospital awarded 15 CIHR grants worth more than $8.4 million
February 3, 2023 - Researchers at The Ottawa Hospital are playing a lead role in 15 new projects awarded more than $8.4 million from the Canadian Institutes of Health Research (CIHR). |
Hold the ice: study shows no benefit during kidney cancer surgery
May 19, 2021 - A clinical trial shows that contrary to popular belief, renal hypothermia doesn’t actually improve kidney function after kidney cancer surgery. |
Clinicians at The Ottawa Hospital launch 14 innovative projects to improve health-care delivery, thanks to funding from TOHAMO and The Ottawa Hospital’s Research Institute
March 22, 2019 - The Ottawa Hospital Academic Medical Organization (TOHAMO) has awarded $1.169 million in Innovation Grants to 14 teams, with supporting funds provided by the Ottawa Hospital Research Institute. |
Researchers to advance science and improve health with new CIHR funding
February 14, 2019 - Researchers at The Ottawa Hospital, affiliated with the University of Ottawa, are playing a lead role in nine new projects funded by the Canadian Institutes of Health Research (CIHR). These projects will advance science and improve health in ... |
To treat, or not to treat? How one man decided to keep his prostate cancer
June 29, 2016 - Stephen Wilson of Iroquois, Ontario avoided unnecessary treatments and side-effects by opting for regular monitoring of his slow-growing prostate cancer.
Dairy plant manager Stephen Wilson faced a tough choice. In December 2012, he had just be |
Can a drug help prevent blood loss during bladder cancer surgery?
May 18, 2016 - Drs. Rodney Breau, Ilias Cagiannos, and Franco Momoli were awarded $400,000 from the Canadian Institutes of Health Research (CIHR) to investigate whether a drug called tranexamic acid can reduce blood loss during surgery for patients with bladder |
Many prostate cancer patients saved from unnecessary treatments and side effects
February 29, 2016 - Low-risk patients increasingly undergoing regular monitoring rather than immediate treatment
Of the approximately 24,000 Canadians diagnosed with prostate cancer each year, about half have a slow-growing form that poses little risk to their he |
Controversial prostate cancer screening can be improved by repeating abnormal tests
December 10, 2015 - For more than 20 years, the prostate-specific antigen (PSA) test has been used to help screen for prostate cancer, but in recent years, some task forces have called for this blood test to be abandoned because it leads to many unnecessary biopsies. No |
Virus vs. Prostate Cancer: Canadian Researchers Pioneer Next-generation Therapy
-- Prostate Cancer Canada and the Movember Foundation partner to make innovative work possible
September 30, 2015 - A multi-disciplinary team of scientists and clinicians led by Dr. John Bell of The Ottawa Hospital is developing a treatment for prostate cancer using viruses that destroy cancer cells and boost the anti-cancer immune response, all the while leaving |
The Ottawa Hospital awarded $28M from Canadian Institutes of Health Research for 22 research projects
July 28, 2015 - Twenty-two teams at The Ottawa Hospital, affiliated with the University of Ottawa, have been awarded more than $28 million in research grants from the Canadian Institutes of Health Research (CIHR). The Honourable Rona Ambrose, Minister of Health for |
